Lista de obras -

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

artículo científico publicado en 2014

Characterization and structural analysis of HIV-1 integrase conservation

artículo científico publicado en 2009

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

artículo científico publicado en 2009

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

article

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

artículo científico publicado en 2012

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro

artículo científico publicado en 2011

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

artículo científico publicado en 2005

Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage

artículo científico publicado en 2011

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure

artículo científico publicado en 2004

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl

artículo científico publicado en 2002

Molecular Diversity of HIV in Albania

article

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

artículo científico publicado en 2004

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

artículo científico publicado en 2010

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

article

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

artículo científico publicado en 2014

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

artículo científico publicado en 2004

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

artículo científico publicado en 2014

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors

artículo científico publicado en 2010

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

artículo científico publicado en 2008

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

article

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

artículo científico publicado en 2012

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme

artículo científico publicado en 2005

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

article

The degree of HIV-1 amino acid variability is strictly related to different disease progression rates

scientific article published on 17 May 2018

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

artículo científico publicado en 2003

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

artículo científico publicado en 2009

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir

artículo científico publicado en 2010

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

artículo científico publicado en 2003

gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure

artículo científico publicado en 2007

Lista de obras de

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

Characterization and structural analysis of HIV-1 integrase conservation

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl

Molecular Diversity of HIV in Albania

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

The degree of HIV-1 amino acid variability is strictly related to different disease progression rates

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure